Stock AnalizMolina Healthcare, Inc. MOH
Medical Specialities · IPO 2003 · data as of November 13, 2026
Molina Healthcare, Inc. (MOH) is a healthcare company listed in the US with a market value of about $10.9B. In the twelve months to September 30, 2026 it had revenue of $44.1B and net income of -$48M, a net margin of -0.1%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is track record (3/5); the weakest is value (0/5).
Key numbers: a price to free cash flow of 45.9, 5-year revenue growth of 19% a year, a 5-year average ROIC of 15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 8% below the current price.
Score: 1.8 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Positive free cash flow
- Share count down over 3 years (buybacks)
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.1B | $45.4B | $40.6B | $34.1B | $32.0B | $27.8B | $19.4B | $16.8B | $18.9B | $19.9B | $17.8B |
| Net income | -$48M | $472M | $1.2B | $1.1B | $792M | $659M | $673M | $737M | $707M | -$512M | $52M |
| Free cash flow | $238M | -$636M | $544M | $1.6B | $682M | $2.0B | $1.8B | $377M | -$344M | $718M | $497M |
| EPS (diluted) | $-0.68 | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 |
| Net margin | -0.1% | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.3% |
| ROIC | — | 7.9% | 16.8% | 18.0% | 16.6% | 15.5% | 17.5% | 24.0% | 25.8% | -13.2% | 7.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 17 analysts is $219.53, 5% above the current price; targets range from $163.00 to $266.00; the consensus rating is “Hold”; expected EPS is $5.27 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Molina Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 8% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Molina Healthcare pay a dividend?
Not currently.
Is Molina Healthcare a good stock to buy?
We do not give buy or sell advice. Molina Healthcare scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.